Page 31 - 《中国药房》2021年07期

[ 9 ] Agence Nationale de Sécurité du Médicament et des Pro- （5）：385-396.
duits de Santé. Charter for the communication and promo- [21] STRICKER B H，PSATY B M. Detection，verification，
tion of health products（drugs and medical devices）on in- and quantification of adverse drug reactions[J]. BMJ，
ternet and e-media[EB/OL].（2014-04-07）[2020-05-07]. 2004，329（7456）：44-47.
http：//ansm.sante.fr/content/download/61269/786823/ver- [22] VAN STEKELENBORG J，ELLENIUS J，MASKELL S，
sion/1/file/Charte-Internet-2014.pdf. et al. Recommendations for the use of social media in
[10] Agenzia Italiana del Farmaco. Communication to pharma- pharmacovigilance：lessons from IMI WEB-RADR[J].
ceutical industry：update on provisions regarding the ma- Drug Saf，2019，42（12）：1393-1407.
nagement and reporting of Italian reports of suspected ad- [23] SLOANE R，OSANLOU O，LEWIS D，et al. Social media
verse reactions when reporter’s information is not avai- and pharmacovigilance：a review of the opportunities and
lable[EB/OL].（2014-07-02）[2020-06-02]. http：//www. challenges[J]. Br J Clin Pharmacol，2015，80（4）：910-920
agenziafarmaco.gov.it/it/content/nuove-modalit％C3％A0- [24] NGUYEN D，GRAVEL R，TRIESCHNIGG D，et al.“How
di-gestione-le-segnalazioni-di-adr-aggiornamento07022014. old do you think I am?”A study of language and age in
[11] 袁林，高燕，路长飞.我国建立药物警戒制度的初步思 Twitter[C]//Proceedings of the Seventh International
考[J].中国药物警戒，2020，17（11）：749-752. AAAI Conference on Weblogs and Social Media. Palo Al-
[12] 全国人民代表大会常务委员会.中华人民共和国药品管 to：AAAI Press，2013：439-448.
理 法 [S/OL].（2019-08-06）[2020-06-03].http：//www.npc. [25] MISLOVE A，LEHMANN S，AHN Y Y. Understanding
gov.cn/npc/c30834/201908/26a6b28dd83546d79d17f90c- the demographics of Twitter users[C]. Barcelona：5th In-
62e59461.shtml. ternational AAAI Conference on Weblogs and Social Me-
[13] CONVERTINO I，FERRARO S，BLANDIZZI C，et al. dia（ICWSM），2011.
The usefulness of listening social media for pharmacovigi- [26] NAIK P，UMRATH T，VAN STEKELENBORG J，et al.
lance purposes：a systematic review[J]. Expert Opin Drug Regulatory definitions and good pharmacovigilance prac-
Saf，2018，17（11）：1081-1093. tices in social media：challenges and recommendations[J].
[14] PAPPA D，STERGIOULAS L K. Harnessing social media Ther Innov Regul Sci，2015，49（6）：840-851.
data for pharmacovigilance：a review of current state of [27] ICH. ICH guidelines[EB/OL].（2011-05-02）[2020-05-21].
the art，challenges and future directions[J]. IJDSA，2019，8 http：//www.ich.org/products/guidelines.
（2）：113-135. [28] 中国互联网络信息中心.第47次中国互联网络发展状况
[15] LIU X，CHEN H. A research framework for pharmacovigi- 统计报告[EB/OL]. [2021-02-03]. http：//www.cnnic.net.
lance in health social media：identification and evaluation cn/hlwfzyj/hlwxzbg/hlwtjbg/202102/t20210203_71361.
of patient adverse drug event reports[J]. J Biomed Inform， htm.
2015，58：268-279. [29] JEON E，PARK H A. Factors affecting acceptance of smart-
[16] CHEN X，FAVIEZ C，SCHUCK S，et al. Mining patients’ phone application for management of obesity[J]. Healthc
narratives in social media for pharmacovigilance：adverse Inform Res，2015，21（2）：74-82.
effects and misuse of methylphenidate[J]. Front Pharma- [30] SCHEIBE M，REICHELT J，BELLMANN M，et al. Ac-
col，2018，9：541. ceptance factors of mobile apps for diabetes by patients
[17] 王芳芳，陈维红，王斌，等.基于手机应用程序用药软件药 aged 50 or older：a qualitative study[J]. Med 2.0，2015，4
物警戒模块的构建[J].中国药物与临床，2019，19（15）： （1）：e1.
2527-2529. [31] CORDOVA D，BAUERMEISTER J A，FESSLER K，et al.
[18] PIERCE C E，BOURI K，PAMER C，et al. Evaluation of A community-engaged approach to developing an
facebook and twitter monitoring to detect safety signals mHealth HIV/STI and drug abuse preventive intervention
for medical products：an analysis of recent FDA safety for primary care：a qualitative study[J]. JMIR Mhealth
alerts[J]. Drug Saf，2017，40（4）：317-331. Uhealth，2015，3（4）：e106.
[19] CURTIS J R，CHEN L，HIGGINBOTHAM P，et al. Social [32] 国家药品监督管理局药品评价中心.关于发布《个例安全
media for arthritis-related comparative effectiveness and 性报告 E2B（R3）区域实施指南》的通知[EB/OL].（2019-
safety research and the impact of direct-to-consumer ad- 11-22）[2020-05-22].http：//www.cdr-adr.org.cn/drug_1/
vertising[J]. Arthritis Res Ther，2017，19（1）：48. ICHzd_1/ICH_E2B/201911/t20191122_46834.html.
[20] HAZELL L，SHAKIR S A. Under-reporting of adverse （收稿日期：2020-06-11 修回日期：2021-01-29）
drug reactions：a systematic review[J]. Drug Saf，2006，29 （编辑：罗 瑞）

中国药房 2021年第32卷第7期 China Pharmacy 2021 Vol. 32 No. 7 ·793 ·